Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PET/Alzheimer’s Study To Be First CMS-Funded Practical Clinical Trial – Tunis

This article was originally published in The Gray Sheet

Executive Summary

CMS plans to release a position paper on new and ongoing initiatives related to improving the quality of clinical evidence, according to Chief Medical Officer Sean Tunis, MD

You may also be interested in...



PET Groups Carp On CMS Coverage Policy, National Coverage Decision Delay

CMS' cautious approach to covering positron emission tomography indications has spurred criticism among the PET industry, which seeks to accelerate reimbursement to drive the technology's adoption

PET Groups Carp On CMS Coverage Policy, National Coverage Decision Delay

CMS' cautious approach to covering positron emission tomography indications has spurred criticism among the PET industry, which seeks to accelerate reimbursement to drive the technology's adoption

CMS New Tech Council Expected To Meet This Fall

A public meeting of CMS' Council for Technology & Innovation is expected to be held in October, the first in a planned series of open door forums, stakeholder meetings and workshops on new technology issues

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020627

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel